Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
This study has been completed.
Study NCT00431015   Information provided by Infinity Pharmaceuticals, Inc.

First Received on January 31, 2007.   Last Updated on December 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial